Camber Pharmaceuticals: Your Lifeline for Quality, Integrity and Value in Generics
Camber's impressive growth is tied to quality, service and teamwork.
Camber’s impressive growth is tied to quality, service and teamwork.
Camber has been recognized as one of the Top 15 pharmaceutical companies in overall dispensed prescriptions and # 1 in growth among generics with an al-most 20% increase in 2014. Camber’s commitment to its customers is to bring the highest quality generic pharmaceuticals to the market with a simple product strategy; capitalize on its core strengths to deliver maximum profitability to its customers.
Kon Ostaficiuk, President of Camber Pharmaceuticals talks about Camber’s growth formula and some plans for the future. “Our growth begins with a commitment by each individual in our company to never lose sight of the needs of our customers” says Ostaficiuk. “From sales, to pricing, to customer service, everyone is pulling in the same direction. We know we have to earn our customers business every day and in every way. So if it means developing a customized program for a particular partner, or staying late on a holiday weekend to make sure all our orders are shipped, it’s really just part of the culture here at Camber.”
Strong Global Resources are a Distinct Advantage
Camber is a fully integrated interna-tional pharmaceutical company that maintains quality and integrity in all its products, from API manufacturing to finished dosage. Camber is a wholly owned subsidiary of Hetero Drugs based in Hyderabad, India.
“We are in the Life Saving Business”
Ostaficiuk continues, “As the Chairman of Hetero, Dr. B.P.S Reddy likes to say; we are in the life saving business.” Hetero’s business model is based on providing affordable, lifesaving medications to as many people as possible. An example of that is their dedication to improve the quality of life for HIV patients worldwide. In addition to being a member of PEPFAR (Presidents Emergency Plan for AIDS Relief), Hetero and Camber currently provide anti-retroviral medications to some 3.5 million patients in 140 countries.
Camber is maintaining an aggressive new product launch schedule. They have already launched 7 new products since January, (Valsartan, Zolmitriptan, Pantoprazole, Rizatriptan, Sildenafil, Famciclovir and Aripiprazole), and have 20 or so more in the pipeline.
Introducing Camber’s OTC division, Camber Consumer Care
Camber has also launched a new OTC division of Camber Pharmaceuticals called Camber Consumer Care, which will focus on the Pain, Allergy, Sleep and Cough/Cold categories.
“We believe our current success, great reputation and strong existing customer relationships will give us a good opportunity to break into and thrive in the competitive OTC marketplace” states Ostaficiuk.